Based on the genetic evidence that nearly all mutations associated with inherited AD variants are associated with alterations in Aβ production or aggregation, advances in genetic engineering technologies have enabled the development of mouse models using the APP and PSEN1 genes. This evidence concerns the gene PSEN1 and Alzheimer disease.